Close

Sage Therapeutics (SAGE) PT Raised to $98 at BofA Securities; Top SMID Biotech Pick for 1st-Half

January 7, 2020 7:22 AM EST Send to a Friend
BofA Securities analyst Tazeen Ahmad raised the price target on Sage Therapeutics (NASDAQ: SAGE) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login